CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +10,000 | $10.95 | $110K | 68,116 |
| 2024-05-20 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $49.99 | $500K | 58,116 |
| 2024-05-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 22,604 | ||
| 2024-05-17 | Halpin Michael Chief Operating Officer | Option exercise | +2,063 | $2.65 | $5K | 3,152 |
| 2024-05-17 | Halpin Michael Chief Operating Officer | Option exercise | +3,132 | $7.20 | $23K | 6,284 |
| 2024-05-17 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | +2,063 | 0 | ||
| 2024-05-17 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | +3,132 | 0 | ||
| 2024-05-16 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,252 |
| 2024-05-16 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $47.85 | $837K | 220,752 |
| 2024-05-16 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 210,000 | ||
| 2024-05-15 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 238,252 |
| 2024-05-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $49.67 | $869K | 220,752 |
| 2024-05-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 227,500 | ||
| 2024-05-01 | WRIGHT LISA Director | Option exercise | +3,200 | 9,017 | ||
| 2024-05-01 | WRIGHT LISA Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2024-05-01 | WRIGHT LISA Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2024-05-01 | WRIGHT LISA Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2024-05-01 | ZERBE ROBERT L MD Director | Option exercise | +3,200 | 26,595 | ||
| 2024-05-01 | ZERBE ROBERT L MD Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2024-05-01 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 |
Page 26 of 75 · 1,497 trades